Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SciBase Holding AB (publ) (SCIB.ST)
SEK33.80
+0.10 (+0.30%)
SE STO Healthcare Medical - Devices
Address
Landsvägen 39 172 63
Sundbyberg, SE
Sundbyberg, SE
CEO
Pia Renaudin
Website
scibase.com
IPO
2015-06-02
ISIN SE0029277631
Description
SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key offerings, Nevisense and Nevisense Go, comprise a point-of-care platform designed for the detection of melanoma and non-melanoma skin cancers, as well as for evaluating skin barrier function. The company also maintains a collaborative agreement with the Advanced Dermatology and Cosmetic Surgery (ADCS) group.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
SEK33.80
+0.10 (+0.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5.7K
Beta
0.03
Float Shares
321.80M
Free Float %
78.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.22% | +9.44% | +20.21% | +70.57% | +89.12% | +80.80% | +7.88% | -70.22% | -92.81% | -98.08% | -99.04% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
33.80
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-22.94
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+36.2% ★ Q1'26: +61.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+41.2% ★ Q1'26: +67.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-207.0% Q1'26: -186.1% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-210.5% Q1'26: -169.3% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: -896.6% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+143.0% Q1'26: +174.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.00× Q1'26: -0.26× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.15M
est: 5.00M (-17.0%)
|
6.44M
est: 7.00M (-8.1%)
|
6.86M
est: 6.94M (-1.2%)
|
6.90M
est: 6.93M (-0.4%)
|
9.28M
est: 9.92M (-6.5%)
|
9.52M
est: 9.00M (+5.8%)
|
11.73M
est: 13.00M (-9.8%)
|
17.89M
est: 17.70M (+1.1%)
|
23.25M
est: 25.71M (-9.6%)
|
29.71M
est: 29.00M (+2.4%)
|
40.46M
est: 39.65M (+2.0%)
|
69.80M
69.80M – 69.80M
+76.0% YoY
|
104.20M
104.20M – 104.20M
+49.3% YoY
|
152.30M
152.30M – 152.30M
+46.2% YoY
|
| EBITDA |
-41.36M
est: -5.00M (-727.2%)
|
-52.75M
est: -7.00M (-653.6%)
|
-41.70M
est: -6.94M (-501.0%)
|
-43.18M
est: -6.93M (-523.2%)
|
-36.72M
est: -9.92M (-270.2%)
|
-32.19M
est: -9.00M (-257.6%)
|
-38.58M
est: -13.00M (-196.8%)
|
-39.33M
est: -17.70M (-122.2%)
|
-51.83M
est: -25.71M (-101.6%)
|
-57.59M
est: -29.00M (-98.6%)
|
-81.49M
est: -39.65M (-105.5%)
|
-69.80M
-69.80M – -69.80M
-76.0% YoY
|
-104.20M
-104.20M – -104.20M
-49.3% YoY
|
-152.30M
-152.30M – -152.30M
-46.2% YoY
|
| EBIT |
-41.53M
est: -5.00M (-730.6%)
|
-53.09M
est: -7.00M (-658.4%)
|
-42.42M
est: -6.94M (-511.4%)
|
-44.03M
est: -6.93M (-535.5%)
|
-39.57M
est: -9.92M (-298.9%)
|
-35.01M
est: -9.00M (-289.0%)
|
-41.78M
est: -13.00M (-221.3%)
|
-42.98M
est: -17.70M (-142.8%)
|
-55.22M
est: -25.71M (-114.8%)
|
-60.83M
est: -29.00M (-109.7%)
|
-85.18M
est: -39.65M (-114.8%)
|
-69.80M
-69.80M – -69.80M
-76.0% YoY
|
-104.20M
-104.20M – -104.20M
-49.3% YoY
|
-152.30M
-152.30M – -152.30M
-46.2% YoY
|
| Net Income |
-41.53M
est: -688.90M (+94.0%)
|
-53.09M
est: -665.80M (+92.0%)
|
-42.46M
est: -260.71M (+83.7%)
|
-44.22M
est: -275.29M (+83.9%)
|
-39.54M
est: -246.98M (+84.0%)
|
-34.99M
est: -183.64M (+80.9%)
|
-41.69M
est: -185.93M (+77.6%)
|
-39.90M
est: -86.38M (+53.8%)
|
-55.59M
est: -199.91M (+72.2%)
|
-61.13M
est: -108.11M (+43.5%)
|
-87.06M
est: -40.08M (-117.2%)
|
36.04M
36.04M – 36.04M
+189.9% YoY
|
36.04M
36.04M – 36.04M
+0.0% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
31.57M
est: 13.62M (+131.8%)
|
34.73M
est: 19.06M (+82.2%)
|
31.92M
est: 18.90M (+68.9%)
|
32.85M
est: 18.87M (+74.1%)
|
31.53M
est: 27.01M (+16.7%)
|
29.97M
est: 24.51M (+22.3%)
|
37.07M
est: 35.40M (+4.7%)
|
46.81M
est: 48.20M (-2.9%)
|
54.56M
est: 65.07M (-16.1%)
|
69.61M
est: 73.39M (-5.2%)
|
88.43M
est: 100.34M (-11.9%)
|
176.65M
176.65M – 176.65M
+76.0% YoY
|
263.70M
263.70M – 263.70M
+49.3% YoY
|
385.43M
385.43M – 385.43M
+46.2% YoY
|
| EPS |
-3.55
est: -3.87 (+8.3%)
|
-3.82
est: -3.74 (-2.1%)
|
-2.98
est: -1.46 (-103.5%)
|
-1.59
est: -1.55 (-2.8%)
|
-1.42
est: -1.39 (-2.3%)
|
-1.09
est: -1.03 (-5.6%)
|
-0.64
est: -1.04 (+38.7%)
|
-0.57
est: -0.49 (-17.4%)
|
-0.51
est: -0.46 (-10.3%)
|
-0.34
est: -0.25 (-36.0%)
|
-0.20
est: -0.09 (-115.8%)
|
0.08
0.08 – 0.08
+189.9% YoY
|
0.08
0.08 – 0.08
+0.0% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-81.17M
OE per share TTM
-0.22
Owner's Yield
-36.05%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
33.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-26.6K
Shares Outstanding
410.98M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pia Renaudin | Chief Executive Officer | 4M | female |
| Per Svedenhag | Head of Business Development | 1M | male |
| Michael Colérus | Chief Financial Officer | 272.5K | male |
| Linn Olsen | Chief Operating Officer | — | female |
| Stig Ollmar | Founder & Chief Scientific Officer | — | — |
| Angelica Korsfeldt | Chief Technology Officer | — | female |
| Tobias Bergenblad | Global Sales Director | — | male |
| Jennifer Sparen Bengtsson | Head of Sales & Marketing | — | — |
| Leda Beaty | President of SciBase Inc | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SCIB.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
